• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

私立医院成年体检患者中非酒精性脂肪性胰腺疾病(NAFPD)的患病率及其危险因素:一项大型横断面研究。

Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study.

作者信息

Lesmana Cosmas Rinaldi A, Pakasi Levina S, Inggriani Sri, Aidawati Maria L, Lesmana Laurentius A

机构信息

Digestive Disease & GI Oncology Center, Medistra Hospital, Jakarta, Indonesia.

Department of Internal Medicine, Hepatobiliary Division, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia.

出版信息

BMC Gastroenterol. 2015 Dec 12;15:174. doi: 10.1186/s12876-015-0404-1.

DOI:10.1186/s12876-015-0404-1
PMID:26652175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677042/
Abstract

BACKGROUND

The clinical significance of non-alcoholic fatty pancreatic disease (NAFPD) or fatty pancreas is largely unknown. It is often an incidental finding on abdominal ultrasound, which is not explored further, especially its association with metabolic condition and the risk of pancreatic malignancy. The aim of this study is to evaluate the presence of NAFPD and its associated risk factors among adult medical check-up patients.

METHOD

A large cross-sectional study was done among adult medical check-up patients underwent abdominal ultrasound between January and December 2013 in Medistra Hospital, Jakarta. Data was obtained from the patients' medical record and include demographic data, blood pressures, fasting blood glucose level, and lipid profile. The presence of fatty pancreas was diagnosed by ultrasound. Bivariate and multivariate analyses were done to find associated risk factors for NAFPD. Statistical analysis was done using SPSS version 17.

RESULTS

A total of 1054 cases were included in this study; pancreas cannot be visualized in 153 cases and were excluded from the analysis. Fatty pancreas was present in 315 (35.0%) patients. Bivariate analyses found associations among fatty pancreas and several risk factors such as gender, age, systolic and diastolic blood pressures, body mass index (BMI), fasting plasma glucose (FPG), triglycerides (TG) and cholesterol levels.

CONCLUSION

Fatty pancreas is a common finding during medical check-up with a prevalence of 35%. Fatty pancreas has significant association with metabolic factors and it might have an important role in risk of malignancy.

摘要

背景

非酒精性脂肪性胰腺疾病(NAFPD)或胰腺脂肪变性的临床意义在很大程度上尚不清楚。它常常是腹部超声检查时的偶然发现,并未进一步探究,尤其是其与代谢状况及胰腺恶性肿瘤风险的关联。本研究的目的是评估成年体检患者中NAFPD的存在情况及其相关危险因素。

方法

2013年1月至12月期间,在雅加达Medistra医院对接受腹部超声检查的成年体检患者进行了一项大型横断面研究。数据取自患者病历,包括人口统计学数据、血压、空腹血糖水平和血脂谱。通过超声诊断胰腺脂肪变性。进行双变量和多变量分析以找出NAFPD的相关危险因素。使用SPSS 17版进行统计分析。

结果

本研究共纳入1054例病例;153例病例胰腺无法可视化,被排除在分析之外。315例(35.0%)患者存在胰腺脂肪变性。双变量分析发现胰腺脂肪变性与多个危险因素相关,如性别、年龄、收缩压和舒张压、体重指数(BMI)、空腹血糖(FPG)、甘油三酯(TG)和胆固醇水平。

结论

胰腺脂肪变性在体检中是常见发现,患病率为35%。胰腺脂肪变性与代谢因素有显著关联,可能在恶性肿瘤风险中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79e4/4677042/493a66427693/12876_2015_404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79e4/4677042/493a66427693/12876_2015_404_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79e4/4677042/493a66427693/12876_2015_404_Fig1_HTML.jpg

相似文献

1
Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study.私立医院成年体检患者中非酒精性脂肪性胰腺疾病(NAFPD)的患病率及其危险因素:一项大型横断面研究。
BMC Gastroenterol. 2015 Dec 12;15:174. doi: 10.1186/s12876-015-0404-1.
2
Transabdominal ultrasonography of the pancreas is superior to that of the liver for detection of ectopic fat deposits resulting from metabolic syndrome.经腹超声检查胰腺对于检测代谢综合征导致的异位脂肪沉积优于肝脏检查。
Medicine (Baltimore). 2017 Sep;96(37):e8060. doi: 10.1097/MD.0000000000008060.
3
Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.非酒精性脂肪性胰腺疾病(NAFPD)与代谢综合征的相关性:病例对照回顾性研究。
Cardiovasc Diabetol. 2013 May 20;12:77. doi: 10.1186/1475-2840-12-77.
4
Predictive value of anthropometric and biochemical indices in non-alcoholic fatty pancreas disease: a cross-sectional study.非酒精性脂肪性胰腺疾病的人体测量学和生化指标的预测价值:一项横断面研究。
BMJ Open. 2024 Apr 5;14(4):e081131. doi: 10.1136/bmjopen-2023-081131.
5
Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.非酒精性脂肪性胰腺疾病(NAFPD):沉默的旁观者还是代谢综合征的第五个组分?文献综述
Endocr Metab Immune Disord Drug Targets. 2018;18(6):547-554. doi: 10.2174/1871530318666180328111302.
6
Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China.中国非酒精性脂肪性胰腺疾病的患病率、相关因素及其严重程度
Medicine (Baltimore). 2018 Jun;97(26):e11293. doi: 10.1097/MD.0000000000011293.
7
Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.非酒精性脂肪性胰腺疾病和非酒精性脂肪性肝病:不止是异位脂肪。
Clin Endocrinol (Oxf). 2015 Nov;83(5):656-62. doi: 10.1111/cen.12862. Epub 2015 Aug 12.
8
[Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].[胰腺中的脂质蓄积:非酒精性脂肪性胰腺疾病(NAFPD)的临床意义]
Orv Hetil. 2022 Oct 30;163(44):1735-1742. doi: 10.1556/650.2022.32638.
9
Study of non-alcoholic fatty pancreatic disease among the Egyptian population and the value of serum fatty acid binding protein-1 (FABP-1) as a non-invasive biomarker.埃及人群中非酒精性脂肪性胰腺疾病的研究及血清脂肪酸结合蛋白-1(FABP-1)作为一种非侵入性生物标志物的价值。
Clin Res Hepatol Gastroenterol. 2024 Jun;48(6):102364. doi: 10.1016/j.clinre.2024.102364. Epub 2024 May 23.
10
The association between nonalcoholic fatty pancreas disease and diabetes.非酒精性脂肪性胰腺病与糖尿病之间的关联。
PLoS One. 2013 May 3;8(5):e62561. doi: 10.1371/journal.pone.0062561. Print 2013.

引用本文的文献

1
Significance of Pancreatic Steatosis as a Predictor of New-Onset Diabetes Mellitus Following Pancreatectomy.胰腺脂肪变性作为胰腺切除术后新发糖尿病预测指标的意义
Pancreas. 2025 Jul 18;54(9):e765-75. doi: 10.1097/MPA.0000000000002508.
2
Vanishing pancreas: CT and MRI features and imaging diagnostic strategies.胰腺萎缩:CT与MRI特征及影像诊断策略
Insights Imaging. 2025 Jul 5;16(1):153. doi: 10.1186/s13244-025-01998-4.
3
Fatty Pancreas: Its Potential as a Risk Factor for Pancreatic Cancer and Clinical Implications.脂肪胰腺:其作为胰腺癌风险因素的可能性及临床意义

本文引用的文献

1
Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma.胰腺脂肪浸润与胰腺导管腺癌的关系。
Clin Transl Gastroenterol. 2014 Mar 13;5(3):e53. doi: 10.1038/ctg.2014.5.
2
Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population.神秘的异位脂肪:中国人群中非酒精性脂肪胰腺病的患病率及其相关因素。
J Am Heart Assoc. 2014 Feb 26;3(1):e000297. doi: 10.1161/JAHA.113.000297.
3
Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.
Cancers (Basel). 2025 May 24;17(11):1765. doi: 10.3390/cancers17111765.
4
Optimized Effects of Fisetin and Hydroxychloroquine on ER Stress and Autophagy in Nonalcoholic Fatty Pancreas Disease in Mice.非瑟酮和羟氯喹对小鼠非酒精性脂肪性胰腺疾病内质网应激和自噬的优化作用
J Diabetes Res. 2025 Apr 14;2025:2795127. doi: 10.1155/jdr/2795127. eCollection 2025.
5
Correlation Between Fatty Pancreas and Coronary Artery Calcium Score in a Dyslipidemic Population.血脂异常人群中胰腺脂肪与冠状动脉钙化评分的相关性
Pancreas. 2025 Jul 1;54(6):e547-e554. doi: 10.1097/MPA.0000000000002470.
6
Development and validation of a nomogram based on preoperative factors for predicting clinically relevant postoperative pancreatic fistula following pancreaticoduodenectomy.基于术前因素的列线图在预测胰十二指肠切除术后临床相关胰瘘中的开发与验证
Gland Surg. 2025 Jan 24;14(1):37-47. doi: 10.21037/gs-24-249. Epub 2025 Jan 20.
7
Association between intra-pancreatic fat deposition and diseases of the exocrine pancreas: A narrative review.胰腺内脂肪沉积与胰腺外分泌疾病之间的关联:一项叙述性综述。
World J Gastroenterol. 2025 Jan 14;31(2):101180. doi: 10.3748/wjg.v31.i2.101180.
8
Prevalence of fatty pancreas and its relation with anthropometric values on the Growth and Obesity Cohort Study.生长与肥胖队列研究中脂肪胰腺的患病率及其与人体测量值的关系。
J Pediatr (Rio J). 2025 May-Jun;101(3):362-369. doi: 10.1016/j.jped.2024.09.007. Epub 2024 Dec 7.
9
Extended Review and Updates of Nonalcoholic Fatty Pancreas Disease.非酒精性脂肪性胰腺疾病的扩展综述与更新
Saudi J Med Med Sci. 2024 Oct-Dec;12(4):284-291. doi: 10.4103/sjmms.sjmms_526_23. Epub 2024 Oct 12.
10
Terazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β-cell function in NAFPD by inhibiting MST1-Foxo3a signalling pathway.特拉唑嗪,一种重新利用的GPR119激动剂,通过抑制MST1-Foxo3a信号通路改善非酒精性脂肪性胰腺炎中的线粒体自噬和β细胞功能。
Cell Prolif. 2025 Mar;58(3):e13764. doi: 10.1111/cpr.13764. Epub 2024 Oct 16.
脂肪胰腺、胰岛素抵抗和β细胞功能:使用水脂磁共振成像的人群研究。
Am J Gastroenterol. 2014 Apr;109(4):589-97. doi: 10.1038/ajg.2014.1. Epub 2014 Feb 4.
4
Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.非酒精性脂肪性胰腺疾病(NAFPD)与代谢综合征的相关性:病例对照回顾性研究。
Cardiovasc Diabetol. 2013 May 20;12:77. doi: 10.1186/1475-2840-12-77.
5
The association between nonalcoholic fatty pancreas disease and diabetes.非酒精性脂肪性胰腺病与糖尿病之间的关联。
PLoS One. 2013 May 3;8(5):e62561. doi: 10.1371/journal.pone.0062561. Print 2013.
6
Beta cell dysfunction and insulin resistance.β细胞功能障碍与胰岛素抵抗。
Front Endocrinol (Lausanne). 2013 Mar 27;4:37. doi: 10.3389/fendo.2013.00037. eCollection 2013.
7
Ectopic fat depots and cardiovascular disease.异位脂肪沉积与心血管疾病
Circulation. 2011 Dec 13;124(24):e837-41. doi: 10.1161/CIRCULATIONAHA.111.077602.
8
Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease.非酒精性脂肪肝疾病与非酒精性胰腺疾病有关。
Pancreas. 2010 Nov;39(8):1185-90. doi: 10.1097/MPA.0b013e3181f6fce2.
9
State-of-the-art pancreatic MRI.胰腺磁共振成像的最新技术。
AJR Am J Roentgenol. 2010 Jul;195(1):42-53. doi: 10.2214/ajr.10.4421.
10
MRI-determined fat content of human liver, pancreas and kidney.磁共振成像测定人肝、胰、肾的脂肪含量。
World J Gastroenterol. 2010 Apr 28;16(16):1993-8. doi: 10.3748/wjg.v16.i16.1993.